Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Faxon

Showing results (81-90 of 176) with videos related to

Pageof 18
Sort By:
The American Journal of Cardiology|October 18, 2011
Comparison of three age groups regarding safety and efficacy of drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry)Kevin R Bainey, Faith Selzer, Howard A Cohen, et al.
Journal of the American College of Cardiology|February 16, 2013
Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in patients with type 2 diabetes and stable coronary artery disease: results from the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trialGilles R Dagenais, Jiang Lu, David P Faxon, et al.
Circulation. Cardiovascular Interventions|October 20, 2011
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summaryDavid P Faxon, John W Eikelboom, Peter B Berger, et al.
Circulation|March 30, 2011
Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart diseaseGilles R Dagenais, Jiang Lu, David P Faxon, et al.
Journal of the American College of Cardiology|August 16, 2008
ACC/AHA 2008 Guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic SurgeonsRick A Nishimura, Blase A Carabello, David P Faxon, et al.
Thrombosis and Haemostasis|July 26, 2011
Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspectiveDavid P Faxon, John W Eikelboom, Peter B Berger, et al.
Journal of the American Heart Association|April 26, 2021
Premature Discontinuation of Dual Antiplatelet Therapy After Coronary Stenting in Veterans: Characteristics and Long-Term OutcomesScott Kinlay, Lien Quach, Jean Cormack, et al.
Journal of the American College of Cardiology|May 22, 2002
Improved outcomes for women undergoing contemporary percutaneous coronary intervention: a report from the National Heart, Lung, and Blood Institute Dynamic registryAlice K Jacobs, Janet M Johnston, Amelia Haviland, et al.
American Heart Journal|December 22, 2005
The impact of ejection fraction on outcomes after percutaneous coronary intervention in patients with congestive heart failure: an analysis of the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry and Dynamic RegistryElizabeth M Holper, John Blair, Faith Selzer, et al.
Journal of Medical Economics|April 8, 2014
The cost implications of an early versus delayed invasive strategy in Acute Coronary Syndromes: the TIMACS studyKevin R Bainey, Amiram Gafni, Purnima Rao-Melacini, et al.
Pageof 18

Showing results (81-90 of 176) with videos related to

Sort By:
Pageof 18
The American Journal of Cardiology|October 18, 2011
Comparison of three age groups regarding safety and efficacy of drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry)Kevin R Bainey, Faith Selzer, Howard A Cohen, et al.
Journal of the American College of Cardiology|February 16, 2013
Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in patients with type 2 diabetes and stable coronary artery disease: results from the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trialGilles R Dagenais, Jiang Lu, David P Faxon, et al.
Circulation. Cardiovascular Interventions|October 20, 2011
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summaryDavid P Faxon, John W Eikelboom, Peter B Berger, et al.
Circulation|March 30, 2011
Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart diseaseGilles R Dagenais, Jiang Lu, David P Faxon, et al.
Journal of the American College of Cardiology|August 16, 2008
ACC/AHA 2008 Guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic SurgeonsRick A Nishimura, Blase A Carabello, David P Faxon, et al.
Thrombosis and Haemostasis|July 26, 2011
Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspectiveDavid P Faxon, John W Eikelboom, Peter B Berger, et al.
Journal of the American Heart Association|April 26, 2021
Premature Discontinuation of Dual Antiplatelet Therapy After Coronary Stenting in Veterans: Characteristics and Long-Term OutcomesScott Kinlay, Lien Quach, Jean Cormack, et al.
Journal of the American College of Cardiology|May 22, 2002
Improved outcomes for women undergoing contemporary percutaneous coronary intervention: a report from the National Heart, Lung, and Blood Institute Dynamic registryAlice K Jacobs, Janet M Johnston, Amelia Haviland, et al.
American Heart Journal|December 22, 2005
The impact of ejection fraction on outcomes after percutaneous coronary intervention in patients with congestive heart failure: an analysis of the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry and Dynamic RegistryElizabeth M Holper, John Blair, Faith Selzer, et al.
Journal of Medical Economics|April 8, 2014
The cost implications of an early versus delayed invasive strategy in Acute Coronary Syndromes: the TIMACS studyKevin R Bainey, Amiram Gafni, Purnima Rao-Melacini, et al.
Pageof 18